Home / Import refusals / 8QV-0065443-4/100001/1

8QV-0065443-4/100001/1

Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company — FEI 1719513

Recent inspections

  • 1181795 (NAI Tue Oct 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1053169 (NAI Thu May 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 945648 (VAI Mon Aug 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 832327 (NAI Mon May 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 824146 (VAI Wed Mar 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Compliance actions

Other import refusals

  • AM0-0044795-4/1/4 (Wed Jan 10 2007 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AM0-0044795-4/1/5 (Wed Jan 10 2007 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 823-0118040-0/1/1A (Thu Oct 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 823-0118040-0/1/1B (Thu Oct 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 823-0116869-4/1/1 (Fri Aug 18 2006 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

Refusal Details

Date
February 3, 2026
Country
United States
Product Category
Drugs and Biologics
Product Code
61VBL99 ANTI-FLATULENT N.E.C.
Charges
118,3280